Soleno reveals positive results from DCCR for Prader-Willi Syndrome
Soleno Therapeutics has announced positive top-line results from the randomised withdrawal period of Study C602, a long-term treatment...
top of page
Browse by category
Search
Browse by tag
bottom of page